Gene · 9475
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Machine learning dissection of human accelerated regions in primate neurodevelopment. | Neuron | 2023 | 36640767 | PubTator, text mining | PubMed |
| Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | J Biol Chem | 2023 | 36634849 | PubTator, text mining | PubMed |
| Cytokinesis machinery promotes cell dissociation from collectively migrating strands in confinement. | Sci Adv | 2023 | 36630496 | PubTator, text mining | PubMed |
| ROCK2 interacts with p22phox to phosphorylate p47phox and to control NADPH oxidase activation in human monocytes. | Proc Natl Acad Sci U S A | 2023 | 36626553 | PubTator, text mining | PubMed |
| Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality. | Clin Cancer Res | 2023 | 36622700 | PubTator, text mining | PubMed |
| MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer. | Transl Oncol | 2023 | 36608541 | PubTator, text mining | PubMed |
| Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study. | J Clin Oncol | 2023 | 36608310 | PubTator, text mining | PubMed |
| Preclinical to clinical utility of ROCK inhibitors in cancer. | Trends Cancer | 2023 | 36599733 | PubTator, text mining | PubMed |
| Metformin protects trabecular meshwork against oxidative injury via activating integrin/ROCK signals. | Elife | 2023 | 36598818 | PubTator, text mining | PubMed |
A systematic review on the effects of ROCK inhibitors on proliferation and/or differentiation in human somatic stem cells: A hypothesis that ROCK inhibitors support corneal endothelial healing via acting on the limbal stem cell niche. | Ocul Surf | 2023 | 36586668 | PubTator, text mining | PubMed |
| Chromatin modifiers: A new class of pollutants with potential epigenetic effects revealed by in vitro assays and transcriptomic analyses. | Toxicology | 2023 | 36581016 | PubTator, text mining | PubMed |
| Heparin-mimicking polymer-based hydrogel matrix regulates macrophage polarization by controlling cell adhesion. | Biochem Biophys Res Commun | 2023 | 36580826 | PubTator, text mining | PubMed |
| A Phase I Trial of SYK Inhibition with Fostamatinib in the Prevention and Treatment of Chronic Graft-Versus-Host Disease. | Transplant Cell Ther | 2023 | 36577483 | PubTator, text mining | PubMed |
| α-Synuclein modulates fibronectin expression in the trabecular meshwork independent of TGFβ2. | Exp Eye Res | 2023 | 36539052 | PubTator, text mining | PubMed |
| Decreased B7-H3 promotes unexplained recurrent miscarriage via RhoA/ROCK2 signaling pathway and regulates the secretion of decidual NK cells†. | Biol Reprod | 2023 | 36504380 | PubTator, text mining | PubMed |
| LncRNA ZFAS1 contributes to osteosarcoma progression via miR-520b and miR-520e-mediated inhibition of RHOC signaling. | Clinics (Sao Paulo) | 2023 | 36473367 | PubTator, text mining | PubMed |
| In silico analysis of genomic landscape of SARS-CoV-2 and its variant of concerns (Delta and Omicron) reveals changes in the coding potential of miRNAs and their target genes. | Gene | 2023 | 36470485 | PubTator, text mining | PubMed |
| m6A 'writer' KIAA1429 regulates the proliferation and migration of endothelial cells in atherosclerosis. | Mol Biotechnol | 2023 | 36463391 | PubTator, text mining | PubMed |
| Substrate stiffness enhances human regulatory T cell induction and metabolism. | Biomaterials | 2023 | 36455488 | PubTator, text mining | PubMed |
| Somatic A-to-I RNA-edited RHOA isoform 2 specific-R176G mutation promotes tumor progression in lung adenocarcinoma. | Mol Carcinog | 2023 | 36453714 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9475/papers?page=31